SCHEMBL14469365

SCHEMBL14469365

C=C(N)/C=C(\C=C/N)CN1CCC(C(=O)N2CCN(Cc3c(F)cccc3Cl)CC2)CC1

nearest known ligand 0.48

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 3/20 0.48
▸ POLB P06746 1/20 0.48
▸ TSHR P16473 1/20 0.48
▸ SMN1; SMN2 Q16637 1/20 0.48
▸ ALDH1A1 P00352 5/20 0.47
▸ TDP1 Q9NUW8 2/20 0.47
▸ ALOX15 P16050 1/20 0.47
▸ NPC1 O15118 2/20 0.45
▸ RAB9A P51151 1/20 0.45
▸ LMNA P02545 1/20 0.43
▸ PKM P14618 1/20 0.43
▸ MEN1 O00255 1/20 0.42
▸ KMT2A Q03164 1/20 0.42
▸ DPP8 Q6V1X1 1/20 0.41
▸ USP30 Q70CQ3 1/20 0.41
▸ ACHE P22303 1/20 0.41
▸ GAA P10253 1/20 0.41
▸ ADRB2 P07550 1/20 0.40
▸ CYP2A13 Q16696 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14469573 0.89 MTNR1B (0.39) KDM4EPOLBTSHRSMN1; SMN2ALDH1A1
SCHEMBL14469563 0.89 KDM4E (0.37) KDM4EPOLBTSHRSMN1; SMN2ALDH1A1
SCHEMBL14469188 0.86 ALDH1A1 (0.46) KDM4EPOLBTSHRSMN1; SMN2ALDH1A1
SCHEMBL14469170 0.85 KDM4E (0.48) KDM4ETSHRSMN1; SMN2ALDH1A1ALOX15
SCHEMBL14469294 0.85 ALDH1A1 (0.39) POLBTSHRSMN1; SMN2ALDH1A1NPC1
SCHEMBL14469187 0.84 MEN1 (0.43) KDM4EPOLBTSHRSMN1; SMN2ALDH1A1
SCHEMBL14469186 0.83 ALDH1A1 (0.47) KDM4ETSHRSMN1; SMN2ALDH1A1TDP1
SCHEMBL14469296 0.82 KMT2A (0.43) KDM4EPOLBTSHRSMN1; SMN2ALDH1A1
SCHEMBL14469298 0.82 MEN1 (0.47) KDM4ETSHRSMN1; SMN2ALDH1A1ALOX15
SCHEMBL14469299 0.81 ALDH1A1 (0.36) KDM4EPOLBTSHRSMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007075555-A2 COMBINATION OF AN H3 ANTAGONIST/INVERSE AGONIST AND AN APPETITE SUPPRESSANT SCHERING CORPORATION (US) 2007-07-05 — — WO disclosed
Send feedback